IP Library Granted Patent US 9,138,281
Granted Patent B2
US 9,138,281 · App. 14/034,434 · Granted Sep 22, 2015

Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Douglas Sutton (Pacifica, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/12A61B18/14A61B18/1492A61M5/1408A61N1/0412A61N1/05A61N1/327A61N1/36007A61N1/36017A61B2018/00267A61B2018/00434A61B2018/00577A61M5/14276A61M2210/1082A61N1/0551A61N7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,281
App. No.
14/034,434
Granted
Sep 22, 2015
Kind
B2
Abstract

Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims (49)

1. A method for catheter-based renal neuromodulation of a human patient with a diagnosed condition comprising at least one of heart failure, hypertension, acute myocardial infarction, impaired renal function or chronic renal failure, the method comprising:

positioning a first catheter having a first therapeutic element in a low profile delivery configuration within a first renal blood vessel of the patient and proximate to neural fibers innervating a first kidney of the patient,

wherein the first therapeutic element comprises a first expandable basket sized and shaped for the first renal blood vessel, and wherein the first expandable basket comprises a plurality of first electrodes arranged thereon,

transforming the first therapeutic element from the delivery configuration to a treatment configuration such that the first electrodes on the first expandable basket are in contact with an inner wall of the first renal blood vessel;

inhibiting neural communication along the neural fibers innervating the first kidney via radio frequency (RF) energy from the first electrodes;

positioning a second catheter having a second therapeutic element in a low profile delivery configuration within a second renal blood vessel of the patient and proximate to neural fibers innervating a second kidney of the patient,

wherein the second therapeutic element comprises a second expandable basket sized and shaped for the second renal blood vessel, and wherein the second basket comprises a plurality of second electrodes arranged thereon;

transforming the second therapeutic element from the delivery configuration to a treatment configuration such that the plurality of second electrodes on the second expandable basket are in contact with an inner wall of the second renal blood vessel; and

inhibiting neural communication along the neural fibers innervating the second kidney via RF energy from the second electrodes wherein inhibiting neural communication along the neural fibers innervating the first and second kidney significantly improves a measureable physiological parameter corresponding to the diagnosed condition of the patient.

2. The method of claim 1 wherein the first renal blood vessel has a different diameter than the second renal blood vessel, and wherein, in the treatment configuration, the first basket has a different size than the second basket in the treatment configuration.

3. The method of claim 1 wherein the first renal blood vessel has the same or approximately the same diameter as the second renal blood vessel, and wherein, in the treatment configuration, the first basket is the same size as the second basket in the treatment configuration.

4. The method of claim 1 , further comprising removing the first catheter from the first renal blood vessel of the patient before positioning the second catheter within the second renal blood vessel of the patient.

5. The method of claim 1 wherein positioning the first catheter within the first renal blood vessel of the patient and positioning the second catheter within the second renal blood vessel of the patient occur simultaneously.

6. The method of claim 1 wherein:

positioning the first catheter within the first renal blood vessel of the patient comprises intravascularly delivering the first catheter to the first renal blood vessel over a first guidewire; and

positioning the second catheter within the second renal blood vessel of the patient comprises intravascularly delivering the second catheter to the second renal blood vessel over a second guidewire.

7. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises ablating the neural fibers innervating the first kidney; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises ablating the neural fibers innervating the second kidney.

8. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises denervating the first kidney of the patient; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises denervating the second kidney of the patient.

9. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises denervating the first kidney of the patient; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises denervating the second kidney of the patient.

10. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises reducing renal sympathetic nerve activity of the first kidney; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises reducing renal sympathetic nerve activity of the second kidney.

11. The method of claim 1 wherein:

inhibiting neural communication via RF energy from the first electrodes comprises selectively energizing two or more first electrodes along the first expandable basket to produce a first treatment zone along the first renal blood vessel; and

inhibiting neural communication via RF energy from the second electrodes comprises selectively energizing two or more second electrodes along the second expandable basket to produce a second treatment zone along the second renal blood vessel.

12. The method of claim 1 wherein the first electrodes comprise first bipolar RF electrodes, and wherein the second electrodes comprise second bipolar RF electrodes.

13. The method of claim 1 wherein the first electrodes and second electrodes comprise monopolar electrodes, and wherein

inhibiting neural communication via RF energy from the first electrodes comprises delivering RF energy in a monopolar fashion between the first electrodes and a ground electrode such that the resulting energy field attenuates neural communication along the neural fibers innervating the first kidney; and

inhibiting neural communication via RF energy from the second electrodes comprises delivering RF energy in a monopolar fashion between the second electrodes and the ground electrode such that the resulting energy field attenuates neural communication along the neural fibers innervating the second kidney.

14. A method for catheter-based renal denervation of a human patient, the method comprising:

intravascularly positioning a first catheter having an expandable distal first basket within a first renal artery of the patient;

at least partially ablating nerves along the first renal artery via electric energy from first radio frequency (RF) electrodes carried by the first basket;

intravascularly positioning a second catheter having an expandable distal second basket within a second renal artery of the patient, wherein the second basket is different from the first basket; and

at least partially ablating nerves along the second renal artery via electric energy from second RF electrodes carried by the second basket wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery results in a therapeutically beneficial reduction in blood pressure in the patient.

15. The method of claim 14 wherein:

all or a subset of the plurality of first RF electrodes are dynamically assignable and configured for monopolar use in conjunction with a separate external patient ground; and

all or a subset of the plurality of second RF electrodes are dynamically assignable and configured for monopolar use in conjunction with the separate external patient ground.

16. The method of claim 14 wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

17. The method of claim 14 , further comprising:

monitoring contact between the first RF electrodes and a wall of the first renal artery; and

monitoring contact between the second RF electrodes and a wall of the second renal artery.

18. The method of claim 17 wherein monitoring contact between the first and second bipolar RF electrodes and the walls of the first and second renal arteries, respectitvely, comprises monitoring impedance and/or temperature.

19. The method of claim 17 , further comprising adjusting a treatment parameter in repsonse to the monitoring.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: DEMARAIS, DENISE; GIFFORD, HANSON, III; DEEM, MARK; SUTTON, DOUGLAS; LEVIN, HOWARD R.; GELFAND, MARK
To: ARDIAN, INC.
Reel/Frame 035683/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 035683/0326 →
CHANGE OF NAME Recorded May 20, 2015
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 035749/0795 →
Continuity (19)
Continuation 13361685 · Jan 30, 2012
Division 11368836 · Mar 6, 2006
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation In Part 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60813589 · Dec 29, 2005
Related Publication 20140172054A1 · Jun 19, 2014